6601 - 6625 of 9034 Results
Title
Year
- Essential tremor plus is more common than essential tremor: Insights from the reclassification of a cohort of patients with lower limb tremor2018RESTRICTEDTitle: Essential tremor plus is more common than essential tremor: Insights from the reclassification of a cohort of patients with lower limb tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 56Issue #:Start Page: 109End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.029Citation Count: 76
-
OPENTitle: Anxiety in Parkinson's disease is associated with changes in the brain fear circuitJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 89End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.020Best OA location URL: http://www.prd-journal.com/article/S1353802020307343/pdfCitation Count: 34
-
OPENTitle: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 43Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9360Best OA location URL: https://advances.sciencemag.org/content/advances/6/43/eaaz9360.full.pdfCitation Count: 388
-
OPENTitle: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 88Issue #:Start Page: 156.e11End Page: 156.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085451Citation Count: 20
-
OPENTitle: The pattern of fMRI activation with STN DBS reveals symptom-specific networksJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-026-01368-xBest OA location URL: https://www.nature.com/articles/s41531-026-01368-x_reference.pdfCitation Count: 0
-
RESTRICTEDTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 237End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3589103Citation Count: 0
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
- The footprint of orthostatic hypotension in parkinsonian syndromes2020RESTRICTEDTitle: The footprint of orthostatic hypotension in parkinsonian syndromesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 107End Page: 109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.029Citation Count: 12
-
OPENTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [ 11 C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol: 104Issue #: 4Start Page: 349End Page: 355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
-
OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 33
- A late-onset neurological disorder: is progression inevitable?2022RESTRICTEDTitle: A late-onset neurological disorder: is progression inevitable?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105092End Page: 105092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014Citation Count: 0
- Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor2018RESTRICTEDTitle: Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 129Issue #: 10Start Page: 2215End Page: 2216Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2018.07.024Citation Count: 4
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 69
- Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard2019RESTRICTEDTitle: Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide StandardJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 6Start Page: 2422End Page: 2432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00920Citation Count: 17
- Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability2019RESTRICTEDTitle: Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disabilityJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 87End Page: 93Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.010Citation Count: 31
-
OPENTitle: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?Journal Name: HippocampusPublisher: WileyVol: 27Issue #: 1Start Page: 3End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22671Best OA location URL: https://archive-ouverte.unige.ch/unige:111733Citation Count: 181
- Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: Towards a harmonized segmentation protocol2015RESTRICTEDTitle: Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: Towards a harmonized segmentation protocolJournal Name: NeuroImagePublisher: Elsevier BVVol: 111Issue #:Start Page: 526End Page: 541Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.01.004Citation Count: 367
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial2019RESTRICTEDTitle: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 145End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8Citation Count: 119
-
OPENTitle: A novel homozygous KY variant causing a complex neurological disorderJournal Name: European Journal of Medical GeneticsPublisher: Elsevier BVVol: 63Issue #: 11Start Page: 104031End Page: 104031Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ejmg.2020.104031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7554104Citation Count: 6
-
OPENTitle: Constructing de Novo H2O2 Signaling via Induced Protein ProximityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 6Start Page: 1404End Page: 1410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b00170Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4849873Citation Count: 17
-
OPENTitle: Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker studyJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 33Issue #: 6Start Page: 635End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-023-00974-6Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10840936/pdf/nihms-1925200.pdfCitation Count: 15
- Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI2026RESTRICTEDTitle: Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMIJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78245Citation Count: 0
-
OPENTitle: Automated Quality Control for Sensor Based Symptom Measurement Performed Outside the LabJournal Name: SensorsPublisher: MDPI AGVol: 18Issue #: 4Start Page: 1215End Page: 1215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s18041215Best OA location URL: https://www.mdpi.com/1424-8220/18/4/1215/pdf?version=1525348690Citation Count: 26
-
OPENTitle: Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and CognitionJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 75Issue #: 8Start Page: 748End Page: 754Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/jnen/nlw047Best OA location URL: https://academic.oup.com/jnen/article-pdf/75/8/748/33451979/nlw047.pdfCitation Count: 144
-
OPENTitle: Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 90End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0596-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0596-zCitation Count: 80